SCHEMBL625752

SCHEMBL625752

CCCCCc1ccc(C=O)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
TSHR P16473 1/20 0.55
EPHX2 P34913 1/20 0.49
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HIF1A Q16665 1/20 0.42
EPAS1 Q99814 1/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 3/20 0.41
ALOX5 P09917 2/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
ALOX15 P16050 1/20 0.39
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
STAT1 P42224 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2903199 0.98 ALDH1A1 (0.53) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL22230787 0.98 ALDH1A1 (0.53) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL16901802 0.98 ALDH1A1 (0.53) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL28524361 0.98 ALDH1A1 (0.53) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL25201803 0.98 ALDH1A1 (0.53) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL8635202 0.94 ALDH1A1 (0.57) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL16806596 0.88 ALOX5 (0.50) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL8640022 0.86 ALDH1A1 (0.61) ALDH1A1TSHREPHX2HTTL3MBTL1
SCHEMBL9303004 0.81 CHRM2 (0.50) ALDH1A1TSHRHTTL3MBTL1SMN1; SMN2
SCHEMBL3394938 0.81 EPHX2 (0.54) ALDH1A1EPHX2HIF1AMAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FUGENBIO CO., LTD. (KR) 2025-09-18 US claimed
EP-4516783-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF Fugenbio Co., Ltd. (KR) 2025-03-05 EP claimed
WO-2023211205-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF (주)퓨젠바이오 2023-11-02 WO claimed
WO-2021050927-A2 YEAST-HYDROLYSATE COMPOSITIONS AND METHODS OF THEIR USE California Safe Soil, LLC (US) 2021-03-18 WO claimed
CN-1990477-A Linear dicationic terphenyls and their aza analogues as antiparasitic agents UNIV NORTH CAROLINA CHAPEL HILL (US) 2007-07-04 CN claimed
JP-10218718-A None JP disclosed
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FUGENBIO CO., LTD. (KR) 2025-09-18 US disclosed
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FUGENBIO CO., LTD. (KR) 2025-09-18 US disclosed
EP-4516783-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF Fugenbio Co., Ltd. (KR) 2025-03-05 EP disclosed
EP-4516783-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF Fugenbio Co., Ltd. (KR) 2025-03-05 EP disclosed
WO-2023211205-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF (주)퓨젠바이오 2023-11-02 WO disclosed
WO-2023211205-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF (주)퓨젠바이오 2023-11-02 WO disclosed
CN-101270081-A Linear dicationic terphenyls and aza analogs thereof as antiparasitic agents UNIV GEORGIA STATE (US) 2008-09-24 CN disclosed
CN-1990477-A Linear dicationic terphenyls and their aza analogues as antiparasitic agents UNIV NORTH CAROLINA CHAPEL HILL (US) 2007-07-04 CN disclosed
US-7045640-B2 Method of producing 5-formyl-2-furylboronic acid DEGUSSA AG (DE) 2006-05-16 US disclosed
EP-1403271-B1 Method of producing 5-formyl-2-furylboronic acid DEGUSSA (DE) 2005-11-16 EP disclosed
US-20040127725-A1 Method of producing 5-formyl-2-furylboronic acid DEGUSSA AG (DE) 2004-07-01 US disclosed
EP-1403271-A1 Method of producing 5-formyl-2-furylboronic acid Degussa AG (DE) 2004-03-31 EP disclosed
JP-H10218718-A ANTIMICROBIAL COMPOSITION AND CONTROL OF STORAGE DISORDER OF VEGETABLE AND FRUITS NORIN SUISANSYO YASAI CHIYAGIYOU SHIKENJO 1998-08-18 JP disclosed
US-4792614-A ANTIHYPER CHOLESTEROL AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1988-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289795-A1 METHOD FOR PREPARATION OF COMPOUND POSSESSING 5-PENTYLFURFURAL (5-PF) STRUCTURE AND USE THEREOF FABP4, FABP5, PLIN5 ALDH1A1 236/4885TSHR 2884/4885EPHX2 1498/4885
US-20040127725-A1 Method of producing 5-formyl-2-furylboronic acid FPR2, FPR1, FPR3 ALDH1A1 860/4885TSHR 2348/4885EPHX2 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.